Effects of Progesterone on Transgender Women

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of oral progesterone in transgender women who have been on gender-affirming hormone therapy for at least six months. The primary focus is to assess the impact of progesterone on psychological distress, while secondary outcomes include sleep quality, breast size, quality of life, gender congruence, and cardiovascular risk. Given the limited research on the role of progesterone in this population, the study aims to fill critical gaps in understanding its safety and efficacy. Participants will be randomly assigned to receive either progesterone or a placebo.

Why it matters

Who can join: the full rules

Inclusion Criteria:

\- Participants will be transgender women, who have been on gender-affirming hormone therapy for at least 6 months before the start of the study.

Exclusion Criteria:

* Peanut allergy
* Liver disease (liver enzyme elevations and/or evidence of acute or chronic hepatitis). In our lab, the upper limit of normal for aspartate aminotransferase (AST) is 39, and the upper limit of normal for alanine aminotransferase (ALT) is 52.
* Stage 4/5 chronic kidney disease
* Congestive heart failure
* Medical disease or medication use associated with gynecomastia (i.e tumor, hyperthyroidism, chronic kidney disease, cirrhosis, ACE inhibitors, statins, haloperidol, tricyclic antidepressants, atypical antipsychotics)
* Pre-existing cardiovascular disease
* Prior or current history of thromboembolism, known clotting disorders, current or recent anti-thrombotic therapy for venous thromboembolism.
* History of breast cancer
* Prior progesterone use
* Uncontrolled depression and/or suicidal ideation
* Current hypothyroidism (even if controlled with treatment) Progesterone in Gender Affirming Hormone Therapy 9 Version #4, 10/30/24
* Cannabis use of greater than 1 use/week in the past 3 months
* Previously identified BRCA 1 or 2 gene mutation or other familial breast cancer.
* Abnormal mammogram (if indicated - for patients above the age of 50 and on estrogen for 5 or more years OR positive family history of breast cancer) with results of BIRADS 3 or higher. Subjects with a BIRADS 0 mammogram must have undergone additional imaging demonstrating BIRADS 1 or 2 prior to enrollment.
* Have had or are planning to undergo breast enhancement or gender affirming top surgery in the next 6 months
* Uncontrolled hypertension, defined as systolic blood pressure ≥ 140 mm Hg and/or diastolic blood pressure ≥ 90 mmHg.
* Triglycerides ≥ 500 mg/dL.
* In our lab, the upper limit of normal for aspartate aminotransferase (AST) is 39, and the upper limit of normal for alanine aminotransferase (ALT) is 52.
* Estimated glomerular filtration rate (eGFR) \< 30 mL/min/1.73m2.
* Estradiol levels outside the stable range (100-300 pg/mL)
* Heavy smoking, defined as 25+ cigarettes per day
* Non-English speaking or those with limited English proficiency

Where it's running

• Emory Transgender Clinic
  Atlanta, Georgia, United States Recruiting

Study contacts

• Principal investigator: Vin Tangpricha, MD, PhD — Emory University
• Study coordinator: Vin Tangpricha, MD, PhD
• Email: vin.tangpricha@emory.edu
• Phone: 404-727-7254

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Financial and counseling support for transgender women to improve health services access

  This study tests whether financial help and personalized counseling can make it easier for transgender women to access substance use services and HIV prevention methods like PrEP.

  Recruiting University of Central Florida · Orlando, Florida · NCT06202898

• MRI or CT planning to guide high-dose-rate prostate brachytherapy

  This trial tests whether adding an MRI to CT-based treatment planning for HDR prostate brachytherapy changes urinary side effects in men with localized prostate cancer.

  Recruiting at 3 sites Emory University · Atlanta, Georgia and 2 other locations · NCT07859722

• Fall Prevention Pathways: A digital program to help older adults reduce fall risk

  A digital, remotely monitored 8-week program is being tested to see if it can reduce fall risk in community-dwelling adults aged 65–85 who are at low to moderate risk.

  Recruiting Emory University · Atlanta, Georgia · NCT07824141

• Mobile health navigation to improve breast cancer screening in Kenyan women

  This study tests m-Health patient navigation tools to help women in Kenya access breast cancer screening and early detection services.

  Recruiting Emory University · Atlanta, Georgia · NCT07764796

• Moving Yourself in Space and Time: MYSTIC

  This study tests a music-based stepping therapy to see if people with Parkinson's disease benefit from learning new steps and rhythms set to music.

  Recruiting Emory University · Atlanta, Georgia · NCT07697664

• Exercise-induced brain changes to help leg recovery after subcortical stroke

  Researchers will test whether a 12-week high-intensity cycling program can help improve walking and identify brain and blood markers that predict who benefits among people with chronic subcortical stroke.

  Recruiting at 2 sites Emory University · Atlanta, Georgia and 1 other locations · NCT07663292

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.